Visual Assessment of Chest Computed Tomography Findings in Anti-cyclic Citrullinated Peptide Antibody Positive Rheumatoid Arthritis: Is it Associated with Airway Abnormalities?
详细信息    查看全文
  • 作者:Won Hong Park ; Song Soo Kim ; Seung Cheol Shim ; Seung Taek Song ; Sung Soo Jung
  • 关键词:Lung diseases ; Airway remodeling ; Rheumatoid arthritis ; Autoantibodies ; Computed tomography
  • 刊名:Lung
  • 出版年:2016
  • 出版时间:February 2016
  • 年:2016
  • 卷:194
  • 期:1
  • 页码:97-105
  • 全文大小:667 KB
  • 参考文献:1.Nannini C, Ryu JH, Matteson EL (2008) Lung disease in rheumatoid arthritis. Curr Opin Rheumatol 20:340–346CrossRef PubMed
    2.Gonzalez A, Icen M, Kremers HM et al (2008) Mortality trends in rheumatoid arthritis: the role of rheumatoid factor. J Rheumatol 35:1009–1014PubMedCentral CrossRef PubMed
    3.Lynch DA (2009) Lung disease related to collagen vascular disease. J Thorac Imaging 24:299–309CrossRef PubMed
    4.Bongartz T, Nannini C, Medina-Velasquez YF et al (2010) Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum 62:1583–1591PubMedCentral CrossRef PubMed
    5.Vinik O, Marras T, Shapera S, Mittoo S (2011) Rheumatoid arthritis interstitial lung disease. In: Harjacek M (ed) Challenges in rheumatology. InTech, Rijeka, pp 65–88
    6.Giles JT, Danoff SK, Sokolove J et al (2014) Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease. Ann Rheum Dis 73:1487–1494PubMedCentral CrossRef PubMed
    7.Skare TL, Nakano I, Escuissiato DL, Batistetti R, Rodrigues Tde O, Silva MB (2011) Pulmonary changes on high-resolution computed tomography of patients with rheumatoid arthritis and their association with clinical, demographic, serological and therapeutic variables. Rev Bras Reumatol 51:325-330–336-327PubMed
    8.Zrour SH, Touzi M, Bejia I et al (2005) Correlations between high-resolution computed tomography of the chest and clinical function in patients with rheumatoid arthritis. Prospective study in 75 patients. Joint Bone Spine: revue du rhumatisme 72:41–47CrossRef
    9.Bilgici A, Ulusoy H, Kuru O, Celenk C, Unsal M, Danaci M (2005) Pulmonary involvement in rheumatoid arthritis. Rheumatol Int 25:429–435CrossRef PubMed
    10.Youssef AA, Machaly SA, El-Dosoky ME, El-Maghraby NM (2012) Respiratory symptoms in rheumatoid arthritis: relation to pulmonary abnormalities detected by high-resolution CT and pulmonary functional testing. Rheumatol Int 32:1985–1995CrossRef PubMed
    11.Demoruelle MK, Weisman MH, Simonian PL et al (2012) Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? Arthritis Rheum 64:1756–1761PubMedCentral CrossRef PubMed
    12.van der Woude D (2012) Anti-citrullinated protein antibodies (ACPA) in rheumatoid arthritis: linking genetic predisposition to clinical outcome. In: Department Reumatology. Leiden University, Leiden, pp 11–29
    13.van de Sande MG, de Hair MJ, van der Leij C et al (2011) Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase. Ann Rheum Dis 70:772–777CrossRef PubMed
    14.Klareskog L, Stolt P, Lundberg K et al (2006) A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 54:38–46CrossRef PubMed
    15.Rangel-Moreno J, Hartson L, Navarro C, Gaxiola M, Selman M, Randall TD (2006) Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Investig 116:3183–3194PubMedCentral CrossRef PubMed
    16.Perry E, Kelly C, Eggleton P, De Soyza A, Hutchinson D (2014) The lung in ACPA-positive rheumatoid arthritis: an initiating site of injury? Rheumatology 53:1940–1950CrossRef PubMed
    17.Fischer A, Solomon JJ, du Bois RM et al (2012) Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease. Respir Med 106:1040–1047PubMedCentral CrossRef PubMed
    18.Aletaha D, Neogi T, Silman AJ et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581CrossRef PubMed
    19.American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias (2002) This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 165:277–304
    20.Hansell DM, Bankier AA, MacMahon H, McLoud TC, Muller NL, Remy J (2008) Fleischner society: glossary of terms for thoracic imaging. Radiology 246:697–722CrossRef PubMed
    21.Miller MR, Crapo R, Hankinson J et al (2005) General considerations for lung function testing. Eur Respir J 26:153–161CrossRef PubMed
    22.El-Gabalawy H (2009) The preclinical stages of RA: lessons from human studies and animal models. Best Pract Res Clin Rheumatol 23:49–58CrossRef PubMed
    23.Avouac J, Gossec L, Dougados M (2006) Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 65:845–851PubMedCentral CrossRef PubMed
    24.de Vries-Bouwstra JK, Goekoop-Ruiterman YP, Verpoort KN et al (2008) Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies. Arthritis Rheum 58:1293–1298CrossRef PubMed
    25.Thurlings RM, Vos K, Wijbrandts CA, Zwinderman AH, Gerlag DM, Tak PP (2008) Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response. Ann Rheum Dis 67:917–925PubMedCentral CrossRef PubMed
    26.van Dongen H, van Aken J, Lard LR et al (2007) Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 56:1424–1432CrossRef PubMed
    27.Nielen MM, van Schaardenburg D, Reesink HW et al (2004) Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 50:380–386CrossRef PubMed
    28.Rantapaa-Dahlqvist S, de Jong BA, Berglin E et al (2003) Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 48:2741–2749CrossRef PubMed
    29.Reynisdottir G, Karimi R, Joshua V et al (2014) Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibody-positive rheumatoid arthritis. Arthritis Rheumatol 66:31–39CrossRef PubMed
    30.Turesson C, Jacobsson LTH (2004) Epidemiology of extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol 33:65–73CrossRef PubMed
    31.Metafratzi ZM, Georgiadis AN, Ioannidou CV et al (2007) Pulmonary involvement in patients with early rheumatoid arthritis. Scand J Rheumatol 36:338–344CrossRef PubMed
    32.Ayhan-Ardic FF, Oken O, Yorgancioglu ZR, Ustun N, Gokharman FD (2006) Pulmonary involvement in lifelong non-smoking patients with rheumatoid arthritis and ankylosing spondylitis without respiratory symptoms. Clin Rheumatol 25:213–218CrossRef PubMed
    33.Nannini C, Medina-Velasquez YF, Achenbach SJ et al (2013) Incidence and mortality of obstructive lung disease in rheumatoid arthritis: a population-based study. Arthritis Care Res 65:1243–1250CrossRef
    34.Kochbati S, Boussema F, Ben Miled M et al (2003) Bronchiectasis in rheumatoid arthritis. High resolution computed pulmonary tomography. Tunis Med 81:768–773PubMed
    35.McDonagh J, Greaves M, Wright AR, Heycock C, Owen JP, Kelly C (1994) High resolution computed tomography of the lungs in patients with rheumatoid arthritis and interstitial lung disease. Br J Rheumatol 33:118–122CrossRef PubMed
    36.Mori S, Koga Y, Sugimoto M (2011) Small airway obstruction in patients with rheumatoid arthritis. Mod Rheumatol Jpn Rheum Assoc 21:164–173CrossRef
    37.Wilsher M, Voight L, Milne D et al (2012) Prevalence of airway and parenchymal abnormalities in newly diagnosed rheumatoid arthritis. Respir Med 106:1441–1446CrossRef PubMed
    38.Chan E, Kelly C, Woodhead FA et al (2013) RA-related interstitial lung disease: which factors predict its development? In: Moots RJ (ed) Rheumatology 2013. Oxford University Press, The ICC, Birmingham, p i75
    39.Inui N, Enomoto N, Suda T, Kageyama Y, Watanabe H, Chida K (2008) Anti-cyclic citrullinated peptide antibodies in lung diseases associated with rheumatoid arthritis. Clin Biochem 41:1074–1077CrossRef PubMed
    40.Chen J, Shi Y, Wang X, Huang H, Ascherman D (2013) Asymptomatic preclinical rheumatoid arthritis-associated interstitial lung disease. Clin Dev Immunol 2013:406927PubMedCentral PubMed
    41.Rocha-Munoz AD, Ponce-Guarneros M, Gamez-Nava JI et al (2015) Anti-cyclic citrullinated peptide antibodies and severity of interstitial lung disease in women with rheumatoid arthritis. J Immunol Res 2015:151626PubMedCentral PubMed
    42.Doyle TJ, Patel AS, Hatabu H et al (2015) Detection of rheumatoid arthritis-interstitial lung disease is enhanced by serum biomarkers. Am J Respir Crit Care Med 191:1403–1412CrossRef PubMed
    43.Kallberg H, Ding B, Padyukov L et al (2011) Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis 70:508–511PubMedCentral CrossRef PubMed
    44.Baumgartner KB, Samet JM, Coultas DB et al (2000) Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. Collaborating Centers. Am J Epidemiol 152:307–315CrossRef PubMed
    45.Makrygiannakis D, Hermansson M, Ulfgren AK et al (2008) Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 67:1488–1492CrossRef PubMed
  • 作者单位:Won Hong Park (1)
    Song Soo Kim (1)
    Seung Cheol Shim (2)
    Seung Taek Song (2)
    Sung Soo Jung (3)
    Jin Hwan Kim (1)
    Namkug Kim (4)
    Joon Beom Seo (5)

    1. Department of Radiology, Chungnam National University Hospital, Chungnam National University School of Medicine, 282 Munhwa-ro, Jung-gu, Daejeon, 301-721, Republic of Korea
    2. Division of Rheumatology, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea
    3. Division of Pulmonology, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea
    4. Department of Convergence Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
    5. Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
  • 刊物类别:Medicine
  • 刊物主题:Medicine & Public Health
    Pneumology and Respiratory System
  • 出版者:Springer New York
  • ISSN:1432-1750
文摘
Introduction We aimed to evaluate the association between specific anti-cyclic citrullinated peptide antibody (ACCPA) and pulmonary abnormalities in rheumatoid arthritis (RA) subjects.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700